ACCELERATING DRUG DEVELOPMENT: COMPREHENSIVE PRECLINICAL DMPK SERVICES

Preclinical compound development is a fundamental step in bringing innovative therapies to patients. Enhancing the performance of these therapies requires detailed understanding of their pharmacokinetic (PK) and pharmacodynamic (PD) properties. Comprehensive preclinical DMPK services offer a diverse range of assays designed to characterize the fat